UNSPSC 51282513: Ceftezole

This classification denotes a cephalosporin antibiotic with the molecular formula C13H12N8O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Z86SYP11W, chemically known as (6r,7r)-8-oxo-7-(2-(1h-tetrazol-1-yl)acetamido)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid but generally known as ceftezole, which bears US NIH Compound Identifier 65755. European Medicines Agency schedules Ceftezole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07424MIG.

UNSPSC 51282513 Ceftezole (Commodity) covers antibiotic pharmaceutical products that state and local health agencies procure for emergency preparedness, community health programs, and clinical supply chains. Recent state and local solicitations under this code reveal a mix of warehouse distribution contracts for essential medications and direct procurement of specialized pharmaceuticals to support public health initiatives, though the specific opportunities indexed here show limited direct sourcing of ceftezole itself. Instead, the code appears to capture a broader pharmaceutical procurement activity where health departments and county agencies source critical medications through competitive bidding processes, including piggyback contracts leveraging multi-agency cooperative purchasing consortiums such as MMCAP Infuse and direct county IFBs for community health supplies.

Activity under this code centers on state health departments and county health agencies, with the Illinois Department of Public Health and Seminole County, Florida appearing as recent buyers. The Illinois Department of Public Health awarded a $2,999,999.11 contract to Chartwell Rx LLC through MMCAP Infuse on August 28, 2026 (Bid 26-482DPH-PREPD-B-53392, IFB process) for a 12-month initial term with two renewal options covering pharmaceutical warehouse supply; Seminole County, Florida posted an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Recent activity appears concentrated in Florida and Illinois, with procurement structured around fixed-fee bidding, multi-year terms, and cooperative purchasing vehicles. Vendors should expect compliance requirements including E-Verify, drug-free workplace certification, and specific insurance coverage mandates when bidding these opportunities.